Identification of privileged scaffolds from a diversified chemical library for β-secretase inhibition

Letters in Drug Design and Discovery

Volumn 2, Issue 8, 2005, Pages 595-600

  Pietrancosta, Nicolas ^a   Quéléver, Gilles ^a   Garino, Cédrik ^a   Laras, Younes ^a   Burlet, Stéphane ^a   Kraus, Jean Louis ^a,b  

^a AIX MARSEILLE UNIVERSITÉ   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Alzheimer's disease; Diversified chemical library; Hexahydrobenzothiazole; Privileged structure; Screening; secretase (BACE 1)

Indexed keywords

BENZOTHIAZOLE DERIVATIVE; BETA SECRETASE; BETA SECRETASE INHIBITOR; HEXAHYDROBENZOTHIAZOLE; JLK 1137; JLK 1138; JLK 1154; JLK 1177; JLK 1178; JLK 1179; JLK 1196; JLK 1213; JLK 1214; JLK 1215; JLK 1266; JLK 1267; UNCLASSIFIED DRUG;

ARTICLE; DRUG STRUCTURE; ENZYME ASSAY; ENZYME INHIBITION; PRIORITY JOURNAL;

EID: 29044433673     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018005774717352     Document Type: Article

References (44)

1. Mayer, T. U.; Kapoor, T. M.; Haggarty, S. J.; King, R. W.; Schreiber, S. L.; Mitchison, T. J. Science 1999, 286, 971-974.
2. De Clercq, E. Nat. Rev. Drug Discov. 2003, 2, 581-587.
3. For recent examples of HTS analytical data system, see: Zehender, H.; le Goff, F.; Lehmann, N.; Filipuzzi, I.; Mayr, L. M. J. Biomol. Screen. 2004, 9, 498-505;
4. Lam, R. L.; Welch, W. J. Methods Mol. Biol. 2004, 275 (Chemoinformatics), 301-315.
5. Lipinski, C. A. J, Pharmacol. Toxicol. 2000, 44, 235-249.
6. Desai, P. V.; Patny, A.; Sabnis, Y.; Tekwani, B.; Gut, J.; Rosenthal, P.; Srivastava, A.; and Avery, M. J. Med. Chem. 2004, 47, 6609-6615.
7. Evans, B. E.; Rittle, K. E.; Bock, M. G.; Dipardo, R. M.; Freidinger, R. M.; Whitter, W. L.; Lundell, G. F.; Veber, D. F.; Anderson, P. S.; Chang, R. S. L.; Lotti, V. J.; Cerino, D. J.; Chen, T. B.; Kling, P. J.; Kunkel, K. A.; Springer, J. P.; Hirshfield, J. J. Med. Chem. 1988, 31, 2235-2246.
8. Patchett, A. A.; Nargund, R. P. Ann. Rep. Med. Chem. 2000, 35, 289-298.
9. Horton, D. A.; Bourne, G. T.; Smythe, M. L. Chem. Rev. 2003, 103, 893-930.
10. For a review on 1,4-dihydropyridine privileged structure, see: Triggle, D. J. Mini-Rev. Med. Chem. 2003, 3, 215-223.
11. Poupon, E.; François, D.; Kunesch, N.; Husson, H.-P. J. Org. Chem. 2004, 69, 3836-3841.
12. For a review on the broad spectrum of biological activity of benzodiazepines, see: Cox, E. D.; Cook, J. M. Chem. Rev. 1995, 95, 1797-1842.
13. Terrett, N. K.; Bell, A. S.; Brown, D.; Ellis, P. Bioorg. Med. Chem. Lett. 1996, 6, 1819-1824.
14. Citron, M. Trends Pharmacol. Sci. 2004, 25, 92-97.
15. Yu, G.; Nishimura, M.; Arawaka, S.; Levitan, D.; Zhang, L. L.; Tandon, A.; Song, Y. Q.; Rogaeva, E.; Chen, F. S.; Kawaral, T.; Supala, A.; Levesque, L.; Yu, H.; Yang, D. S.; Holmes, E.; Millman, P.; Liang, Y.; Zhang, D. M.; Xu, D. H.; Sato, C.; Rogaev, E.; Smith, M.; Janus, C.; Zhang, Y. N.; Aebersold, R.; Farrer, L.; Sorbi, S.; Bruni, A.; Fraser, P.; St George-Hyslop, P. Nature 2000, 407, 48-54.
16. Goutte, C.; Tsunozaki, M.; Hale, V. A.; Priess, J. R. Proc. Natl. Acad. Sci. U. S. A. 2002, 99, 775-779.
17. Francis, R.; McGrath, G.; Zhang, J. H.; Ruddy, D. A.; Sym, M.; Apfeld, J.; Nicoll, M.; Maxwell, M.; Hai, B.; Ellis, M. C.; Parks, A. L.; Xu, W.; Li, J. H.; Gurney, M.; Myers, R. L.; Himes, C. S.; Hiebsch, R.; Ruble, C.; Nye, J. S.; Curtis, D. Dev. Cell 2002, 3, 85-97.
18. Hom, R. K.; Gailunas, A. F.; Mamo, S.; Fang, L. Y.; Tung, J. S.; Walker, D. E.; Davis, D.; Thorsett, E. D.; Jewett, N. E.; Moon, J. B.; John, V. J. Med. Chem. 2004, 47, 158-164.
19. Chen, S. H.; Lamar, J.; Guo, D. Q.; Kohn, T.; Yang, H. C.; McGee, J.; Timm, D.; Erickson, J.; Yip, Y.; May, P.; McCarthy, J. Bioorg. Med. Chem. Lett. 2004, 14, 245-250.
20. Schmidt, B. ChemBioChem 2003, 4, 366-378.
21. For examples of nucleosides, see: Mourier, N.; Trabaud, C.; Graciet, J. C.; Simon, V.; Niddam, V.; Faury, P.; Charvet, A. S.; Camplo, M.; Chermann, J. C.; Kraus, J. L. Nucleosides Nucleotides 1995, 14, 1393-1402;
22. Mourier, N.; Trabaud, C.; Niddam, V.; Graciet, J.; Camplo, M.; Chermann, J. C.; Kraus, J. L. Nucleosides Nucleotides 1996, 15, 1397-1409;
23. Mourier, N.; Camplo, M.; Delia Bruna, G. S.; Pellacini, F.; Ungheri, D.; Chermann, J. C.; Kraus, J. L. Nucleosides Nucleotides Nucleic Acids 2000, 19, 1057-1091.
24. For examples of peptides, see: Niddam, V.; Camplo, M.; LeNguyen, D.; Chermann, J. C.; Kraus, J. L. Bioorg. Med. Chem. Letters 1996, 6, 609-614.
25. For examples of linear pseudopeptides, see: Medou, M.; Priem, G.; Rocheblave, L.; Pepe, G.; Meyer, M.; Chermann, J. C.; Kraus, J. L. Eur. J. Med. Chem. 1999, 34, 625-638;
26. and cyclic pseudopeptides, see: Quéléver, G.; Bihel, F.; Kraus, J. L. Org. Biomol. Chem. 2003, 1, 1676-1683.
27. For example of cyclic polyamines, see: Dessolin, J.; Quélé ver, G.; Camplo, M.; Kraus, J. L. Tetrahedron Lett. 1998, 39, 853-856.
28. Trabaud, C.; Dessolin, J.; Camplo, M.; Hantz, O.; Zoulim, F.; Borel, C.; Meyer, M.; Pepe, G.; Chermann, J. C.; Kraus, J. L. Antiviral Chem. Chemother. 1998, 9, 73-84.
29. For examples of coumarins and isocoumarins, see: Petit, A.; Bihel, F.; da Costa, C. A.; Pourquie, O.; Checler, F.; Kraus, J. L. Nat. Cell Biol. 2001, 3, 507-511;
30. Bihel, F.; Quéléver, G.; Lelouard, H.; Petit, A. S.; da Costa, C. A.; Pourquie, O.; Checler, F.; Thellend, A.; Pierre, P.; Kraus, J. L. Bioorg. Med. Chem. 2003, 11, 3141-3152;
31. Garino, C.; Bihel, F.; Souard, F.; Quéléver, G.; Kraus, J. L. Bioorg. Med. Chem. Lett. 2004, 14, 1771-1774.
32. For examples of pyrrolidinone derivatives, see: Bouygues, M.; Médou, M.; Quéléver, G.; Chermann, J. C.; Camplo, M.; Kraus, J. L. Bioorg. Med. Chem. Lett. 1998, 8, 277-280;
33. Courcambeck, J.; Bihel, F.; De Michelis, C.; Quéléver, G.; Kraus, J. L. J. Chem. Soc., Perkin Trans. I 2001, 1421-1430;
34. Quéléver, G.; Bouygues, M.; Kraus, J. L. J. Chem. Soc., Perkin Trans. I 2002, 1181-1189.
35. For examples of cyclic ureas, see: Niddam, V.; Medou, M.; Dessolin, J.; Trabaud, C.; Camplo, M.; Kraus, J. L. J. Heterocyclic Chem. 1997, 34, 829-833.
36. For examples of tetrazoles and aminothiazoles, see: Quélé ver, G.; Burlet, S.; Garino, C.; Pietrancosta, N.; Laras, Y.; Kraus, J. L. J. Comb. Chem. 2004, 6, 695-698.
37. For examples of hexahydrobenzothiazoles, see: Pietrancosta, N.; Maina, F.; Dono, R.; Moumen, A.; Garino, C.; Laras, Y.; Burlet, S.; Quéléver, G.; Kraus, J. L. Bioorg. Med. Chem. Lett. 2005, 15, 1561-1564.
38. Helal, C. J.; Sanner, M. A.; Cooper, C. B.; Gant, T.; Adam, M.; Lucas, J. C; Kang, Z. J.; Kupchinsky, S.; Ahlijanian, M. K.; Tate, B.; Menniti, F. S.; Kelly, K.; Peterson, M. Bioorg. Med Chem. Lett. 2004, 14, 5521-5525.
39. Willand, N.; Beghyn, T.; Nowogrocki, G.; Gesquiere, J. C.; Deprez, B. Tetrahedron Lett. 2004, 45, 1051-1054.
40. Pietrancosta, N.; Quéléver, G.; Laras, Y.; Garino, C.; Burlet, S.; Kraus, J. L. Aust. J. Chem. 2005, 58, 585-594.
41. Bhisetti, G. R.; Saunders, J. O.; Murcko, M. A.; Lepre, C. A.; Britt, S. D.; Come, J. H.; Deninger, D. D.; Wang, T. PCT Int. 02/088101 (2002); Chem. Abstr. 2002, 137, 353007.
42. Miyamoto, M.; Matsui, J.; Fukumoto, H.; Tarui, N. PCT Int. WO 01/187293 (2001); Chem. Abstr. 2001, 135, 371744.
43. John, V.; Beck, J. P.; Bienkowski, M. J.; Sinha, S.; Heinrikson, R L. J. Med. Chem. 2003, 46, 4625-4630.
44. King, L. C.; Hlavacek, R. J. J. Am. Chem. Soc. 1950, 72, 3722-3725.